STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution



STRATEC Biomedical AG 

17.04.2014 20:41

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Financière de l'Echiquier, Paris, France has notified us pursuant to sec. 21 para. 1 WpHG on 17 April 2014, that on 16 April 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 3% and that the percentage of voting rights on that day amounted to 2.96% (348,851 voting rights).


17.04.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  




back